Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Learn effective ways to use your reward points to get the most out of your credit card benefits. Start maximizing your rewards now!
23,429 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Netflix shares jumped after price hikes, signaling pricing power in streaming. This in-depth look explains what happe...
Income investors are eyeing a familiar Dividend King delivering a near-3% yield. This article breaks down what that s...
A niche copper miners ETF has surged more than 150% over the past year as AI data center growth boosts copper demand....
Bond yields jumped to the mid-4% range on the benchmark 10-year, nudging investors to re-evaluate risk. Research Affi...
This article breaks down the expected path for synopsys (snps) 2026 earnings, focusing on AI design driver demand, li...
As ATS gears up for its Q4 2026 results, investors want clarity on revenue momentum, margins, and guidance. This arti...
IBM shares have surged on AI optimism, prompting a disciplined look at entry points. This report analyzes a potential...
Long-dated Treasury ETFs have struggled as long-end yields climb. This piece explains why holding long-duration funds...
Viking isn’t just another cruise line on the stock market. This article breaks down five reasons reasons Viking diffe...
Banks are reviving sign-up bonuses on savings accounts as competition for deposits intensifies. This article breaks d...
In a market rattled by softer data, Coca-Cola’s traditional strengths keep drawing new and seasoned investors alike. ...